Clinical Trial Update: A Trial of the ALK Grass Tablet in Subjects With Hayfever [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the ALK Grass Tablet for allergic rhinitis (hay fever) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ALK Grass Tablet (grass pollen allergen tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED